Menu
Back to User profile » Dr Ni Xie
Papers published by Dr Ni Xie:
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer
Ning L, Xie N
Cancer Management and Research 2024, 16:137-150
Published Date: 8 March 2024
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis
Huo Q, Ning L, Xie N
Breast Cancer: Targets and Therapy 2023, 15:213-226
Published Date: 10 March 2023
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
Zheng YZ, Li JY, Ning LW, Xie N
Breast Cancer: Targets and Therapy 2022, 14:475-487
Published Date: 21 December 2022
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N
International Journal of Nanomedicine 2022, 17:2319-2320
Published Date: 23 May 2022
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N
International Journal of Nanomedicine 2021, 16:1961-1976
Published Date: 8 March 2021
ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes
Li P, Wang J, Wu D, Ren X, Wu W, Zuo R, Zeng Q, Wang B, He X, Yuan J, Xie N
Cancer Management and Research 2019, 11:8111-8123
Published Date: 2 September 2019